PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD. purchased $3.1M of SUJA (indirect holdings)

PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD. purchased 300,000 indirectly-held shares of SUJA LIFE, INC. (SUJA) at an average of $10.42 ($9.90–$10.57, $3.13M total) across 3 trades over 2026-09-03 to 2026-09-08.

Original reporting
SEC EDGAR · PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD.
Published Sep 8, 2026, 11:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 11:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SUJA
Bullish
medium confidence
Mentioned
$SUJA
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SUJABullishMed
01

Why it matters

The filing provides the first public disclosure of a sizable insider stake increase, which may be interpreted as a bullish signal.

02

Market read

New insider purchase could influence short‑term price dynamics for SUJA.

03

What to watch

The purchase was made via an indirect holding; actual control may be limited.

Relevance 7/10Novelty 7/10Timing: filing date 2026-09-08

Background

SEC Form 4 filing by PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD. reporting a 300,000‑share purchase of SUJA Life, Inc.

Company-level read

Ticker impact

$SUJABullishMedium confidence
Context

Form 4 disclosed a $3.1M open‑market purchase by a 10% owner, increasing holdings to 11.9M shares.

Expected impact

Modest upward pressure; price could rise 2‑4% if market digests the news.

Evidence & confidence

The purchase size is material for a micro‑cap, but not large enough to trigger a sharp move.

Market effects

Signals potential confidence in the health‑and‑wellness sector.

Limited to U.S. small‑cap investors.

Minimal; primarily affects SUJA shareholders.

Counterpoint

Insider buying could be a defensive move ahead of upcoming dilution or earnings weakness.

Key entities

  • SUJA Life, Inc.

    US‑listed health‑and‑wellness company (ticker SUJA).

  • PAINE SCHWARTZ FOOD CHAIN FUND V GP, LTD.

    Investor holding a 10% ownership position in SUJA.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SUJAMed

Suja Life Inc (SUJA) (Q3 2026) Earnings Call Highlights: Sales Beat, Margin Pressure

Suja Life Inc (SUJA) reported Q3 2026 net sales of $76.4M, up 3% YoY, beating expectations. Adjusted EBITDA rose to $10.5M, but gross margin fell to 43.9%. The company gained market share in natural healthy beverages and saw strong growth in club and convenience channels. However, it lowered full-year guidance due to grocery channel pressure and increased promotional spend. Management discussed channel shifts, promotional strategies, and category trends during the earnings call.

$SUJAMed

Suja Life: Q3 Earnings Snapshot

Suja Life Inc. (SUJA) reported a Q3 loss of $5.3M, or 22 cents per share, but adjusted earnings of 6 cents per share, beating estimates. Revenue was $76.4M. The company forecasts Q4 revenue of $83.7M-$86.7M and full-year revenue of $351M-$354M, according to Zacks Investment Research.

$SUJAMed

Suja Life Reports Third Quarter 2026 Financial Results

SUJA LIFE, INC. (SUJA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Suja Life Reports Third Quarter 2026 Financial Results Net sales increased 3.3% year-over-year to $76.4 million Updates fiscal year 2026 outlook OCEANSIDE, CA, November 10, 2026 – Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life,” “Suja” or the “Company”), a leading better-for-you beve

Med

Suja Life’s Recent Volatility Masks A Longer Game In Functional Beverages

Suja Life's stock fell to $9 from $18 after lowering full-year guidance due to grocery channel weakness. Investors are exploring lawsuits, citing potential misleading information. Despite Q2 sales growth of 11.6% to $83.9M, sequential sales dropped 21%. The company remains optimistic about its long-term strategy in the functional beverage market, which is expected to reach $400B by 2034.